Literature DB >> 6365132

Characterisation of breast cancer infiltrates using monoclonal antibodies to human leucocyte antigens.

D J Rowe, P C Beverley.   

Abstract

Serial frozen sections from eleven patients with malignant breast tumours and five patients with benign disease were studied by indirect immunoperoxidase using a panel of mouse monoclonal antibodies to human leucocyte antigens. More infiltrating leucocytes were seen in tumour sections than those of benign conditions. A considerable proportion of the infiltrating cells were T cells, and more of these were of the suppressor/cytotoxic subset than the helper/inducer subset. The T cells were apparently not all activated as indicated by lower levels of staining with anti HLA-DR than anti-leucocyte antibody. Diffuse staining was sometimes seen with HLA-DR and T cell subset antibodies. Tumour cells did not stain or were only very weakly positive with anti HLA-A, B, C.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6365132      PMCID: PMC1976689          DOI: 10.1038/bjc.1984.27

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  A comparative study of the incidence of anergy in patients with carcinoma, leukemia, hodgkin's disease and other lymphomas.

Authors:  D LAMB; F PILNEY; W D KELLY; R A GOOD
Journal:  J Immunol       Date:  1962-10       Impact factor: 5.422

2.  Decreased T-lymphocytes in patients with mammary cancer.

Authors:  S E Keller; H L Ioachim; T Pearse; D M Siletti
Journal:  Am J Clin Pathol       Date:  1976-04       Impact factor: 2.493

3.  Macrophage infiltration of breast tumours: a prospective study.

Authors:  I Lauder; W Aherne; J Stewart; R Sainsbury
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

4.  Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells.

Authors:  T Nemoto; T Han; J Minowada; V Angkur; A Chamberlain; L Dao
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

5.  Cellular hypersensitivity to breast cancer. Assessment by a leukocyte migration procedure.

Authors:  M M Black; H P Leis; B Shore; R E Zachrau
Journal:  Cancer       Date:  1974-04       Impact factor: 6.860

6.  Further observations on prognostic factors in cancer of the female breast.

Authors:  S J Cutler; M M Black; T Mork; S Harvei; C Freeman
Journal:  Cancer       Date:  1969-10       Impact factor: 6.860

7.  Prognosis in breast cancer utilizing histologic characteristics of the primary tumor.

Authors:  M M Black; T H Barclay; B F Hankey
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

8.  Immunocompetence, immunosuppression, and human breast cancer. I. An analysis of their relationship by known parameters of cell-mediated immunity in well-defined clinical stages of disease.

Authors:  J A Stein; A Adler; S B Efraim; M Maor
Journal:  Cancer       Date:  1976-09       Impact factor: 6.860

9.  Immunological characterization of mononuclear cells in peripheral blood and regional lymph nodes of breast cancer patients.

Authors:  W Heidenreich; K Jagla; J Schüssler; P Börner; F Dehnhard; J R Kalden; W Leibold; H H Peter; H Deicher
Journal:  Cancer       Date:  1979-04       Impact factor: 6.860

10.  HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2.

Authors:  A McMichael
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  18 in total

1.  Alterations of class I HLA genes in human colon cancers.

Authors:  M Bar-Eli; H Battifora; M J Cline
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

2.  Monoclonal antibody CI-panHu defines a pan-human cell-surface antigen unique to higher primates.

Authors:  T A de Kretser; G T Lee; H J Thorne; D G Jose
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

3.  Clonal analysis and in situ characterization of lymphocytes infiltrating human breast carcinomas.

Authors:  T L Whiteside; S Miescher; J Hurlimann; L Moretta; V von Fliedner
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Lymphoreticular infiltrates in invasive ductal breast cancer. A histological and immunohistological study.

Authors:  H P Horny; H A Horst
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

Review 5.  Adaptive immunity programmes in breast cancer.

Authors:  Frederick S Varn; David W Mullins; Hugo Arias-Pulido; Steven Fiering; Chao Cheng
Journal:  Immunology       Date:  2016-09-20       Impact factor: 7.397

6.  CD4+ T lymphocytes infiltrating human breast cancer recognise autologous tumor in an MHC-class-II restricted fashion.

Authors:  R Dadmarz; M K Sgagias; S A Rosenberg; D J Schwartzentruber
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

7.  In situ quantitation of inflammatory mononuclear cells in ductal infiltrating breast carcinoma. Relation to prognostic parameters.

Authors:  T An; U Sood; T Pietruk; G Cummings; K Hashimoto; J D Crissman
Journal:  Am J Pathol       Date:  1987-07       Impact factor: 4.307

8.  An immunohistologic study of the distribution and status of activation of head and neck tumor infiltrating leukocytes.

Authors:  K Böheim; H Denz; C Böheim; H Glassl; H Huber
Journal:  Arch Otorhinolaryngol       Date:  1987

9.  The altered expression of MHC-class II determinants on monocytes of cancer patients.

Authors:  W Uracz; J Stachura; A Pituch-Noworolska; T Popiela; A Czupryna; M Zembala
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

10.  Study of the relationship between immunohistologically demonstrated lymphocytes infiltrating human breast carcinomas and patients' survival.

Authors:  H O Wintzer; W Bohle; S von Kleist
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.